About Alventa Pharma
Alventa Pharma is a Healthcare company based in Solan (India). It develops and manufactures generic drugs, offers CDMO services, and exports pharmaceuticals globally. It operates on a B2B and CDMO model. Its Indian entity Alventa Pharma Limited reported revenue of ₹143 Cr. Alventa Pharma offers products and services including Tablets, Capsules, Dry Injection, Liquids, and Ointments. Its focus areas include Pharmaceuticals, Generic Drugs, Formulations and Manufacturing. Its competitors include Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx and 3 more; 5 of its 8 listed competitors have raised funding.
Company details
Alventa Pharma Limited, established in 2006, focuses on research, development, and manufacturing of pharmaceutical formulations like tablets and capsules. It operates as a CDMO provider, supplying branded generics and third-party manufacturing to Indian and international companies. Based in Baddi, India, the company ensures high-quality production through WHO-GMP certified facilities and manages distribution to over 25 states and exports to more than 10 countries, addressing healthcare needs efficiently.
- Headquarters Solan, India
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website alventapharma.com
- Legal Name Alventa Pharma Limited
- Date of Incorporation 28 Oct, 2016
- Jurisdiction Kolkata, West Bengal, India
- Annual Revenue₹143 Cr
FY 2025 · +82% YoY
- Net Profit₹2.04 Cr
FY 2025 · 1% margin
- EBITDA₹5.42 Cr
FY 2025 · 4% margin
Associated legal entities of Alventa Pharma
Alventa Pharma operates through Alventa Pharma Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Alventa Pharma Limited CIN U24299WB2016PLC225674 | Active | 28 Oct 2016 | Kolkata, West Bengal | ₹143 Cr | 25 | 3 | View details |
Products & Services of Alventa Pharma
Alventa Pharma offers a comprehensive portfolio of products and services, including Tablets, Capsules, Dry Injection, Liquids, and Ointments.
Manufactures solid oral drugs for various therapeutic uses.
Produces encapsulated medications for disease treatment.
Offers powdered injections for rapid administration.
Provides liquid syrups and suspensions for oral intake.
Delivers topical creams for skin-related conditions.
Supplies sealed liquid injections for precise dosing.
Board of directors of Alventa Pharma Limited (Alventa Pharma)
Alventa Pharma Limited is the primary company behind Alventa Pharma. The board of Alventa Pharma Limited currently have 3 directors; the longest-serving is Anand Kumar Parmanandka, appointed in 2018. 6 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Anand Kumar Parmanandka DIN 08518622 | Additional Director | 29 Apr 2018 | 8 yrs 5 mo | Alventa Pharma Limited |
| Rubi Mukhopadhyay DIN 08115122 | Director | 04 Jun 2018 | 8 yrs 4 mo | Alventa Pharma Limited |
| Biswajit Pan DIN 08473723 | Director | 07 Jun 2019 | 7 yrs 4 mo | Alventa Pharma Limited |
Financials of Alventa Pharma
Figures of Alventa Pharma Limited, the primary company behind Alventa Pharma, for FY 2025. Revenue was ₹143 Cr (+82% year on year). Net profit was ₹2.04 Cr (1% margin). EBITDA was ₹5.42 Cr (4% margin). Revenue has grown at a compounded annual rate of +10% over three years and +45% over five years.
- ₹143 CrRevenue · FY 2025 · +82% YoY
- ₹2.04 CrNet profit · 1% margin
- ₹5.42 CrEBITDA · 4% margin
- ₹35.1 LakhPaid-up capital
- 25Employees (provident fund records)
- +10%Revenue CAGR, 3 years
- +45%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Alventa Pharma Limited are on its company page.
Detailed financial statements for Alventa Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Alventa Pharma
Alventa Pharma has 8 listed competitors in our database, 5 of them funded. They include Unither, Akums, Jubilant Life Sciences, Recipharm and CoreRx, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| unither-pharma.com | 1993 | Paris, France | – | – | Contract development and manufacturing organization for proprietary and generic drugs | |
| akums.in | 2004 | Delhi, India | $70M | 395 | CDMO focusing on spectrum of dosage forms and therapeutic segments | |
| jubl.com | 1978 | Noida, India | – | – | Company offering a suite of R&D and manufacturing services for small molecules and generics | |
| recipharm.com | 1995 | Jordbro, Sweden | – | 1,083 | Pharmaceutical development and manufacturing services are offered contractually. | |
| corerxpharma.com | 2006 | Clearwater, United States | $15M | – | CDMO with a focus on early phase drug product development | |
| neclife.com | 1995 | Chandigarh, India | $46.85M | 175 | Cephalosporin APIs and generic formulations are manufactured. | |
| windlas.com | 2001 | Gurugram, India | $12.96M | 1,264 | Biopharma regulatory affairs, quality control, and strategy services are provided. | |
| kezzler.com | 2001 | Oslo, Norway | $6.73M | – | Mass serialization solutions for a wide range of industries |
Detailed competitors of Alventa Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Pharmaceuticals & Distribution
10 companies that operate in the same segment as Alventa Pharma (Pharmaceuticals & Distribution), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Pharmaceutical products are manufactured and marketed worldwide. | 1891 | Kenilworth, Warwickshire, United Kingdom | – | USD 64.93 B | 781 | |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. | 2014 | New York, New York, United States | USD 1.3 B | USD 8.26 M | 750 | |
Developer of pharmaceutical products for treating multiple diseases | 1980 | Thousand Oaks, California, United States | – | USD 33.23 B | 28,000 | |
Biopharmaceutical research and drug development are conducted globally by AbbVie. | 2012 | Chicago, Illinois, United States | – | USD 61.16 B | 55,000 | |
Traditional pharmaceutical medicines are developed for multiple health fields. | 1876 | United States | – | USD 65.18 B | 47,000 | |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others | 1987 | Foster City, California, United States | – | USD 29.45 B | 17,600 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
Treatments for anemia and fibrosis by exploiting connective tissue growth factor (CTGF) and hypoxia-inducible factor (HIF) biology. | 1993 | San Francisco, California, United States | USD 213.52 M | USD 29.62 M | 225 | |
Developer of medical devices, generic pharmaceuticals, and nutrition products | 1888 | Libertyville, Illinois, United States | – | USD 44.33 B | 3,710 | |
Medicines and health products are retailed through pharmacy outlets. | 2006 | Hyderabad, Telangana, India | USD 268.78 M | USD 734.57 M | 25,010 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Alventa Pharma
Complete news archive for Alventa Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Alventa Pharma
Alventa Pharma is headquartered in Solan, India. It is registered at Solan, Himachal Pradesh, India.
The primary company behind Alventa Pharma, Alventa Pharma Limited, reported revenue of ₹143 Cr for FY 2025, up 82% year on year.
Alventa Pharma Limited, established in 2006, focuses on research, development, and manufacturing of pharmaceutical formulations like tablets and capsules. It operates as a CDMO provider, supplying branded generics and third-party manufacturing to Indian and international companies. Based in Baddi, India, the company ensures high-quality production through WHO-GMP certified facilities and manages distribution to over 25 states and exports to more than 10 countries, addressing healthcare needs efficiently.
Alventa Pharma's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Alventa Pharma offers Tablets, Capsules, Dry Injection, Liquids, and 2 more products and services.
Alventa Pharma operates through Alventa Pharma Limited.
The legal entities of Alventa Pharma currently have 3 directors, including Anand Kumar Parmanandka, Rubi Mukhopadhyay, Biswajit Pan.